Primo Brands Corp (PRMB) · Aug 5, 2026 · Company update
Profit beat and sales outlook rose, but EBITDA target stayed flat.
The quarter cleared the profit bar, while revenue was roughly in the expected range. Published estimates ahead of the release put adjusted EPS around $0.32-$0.35 and revenue around $1.77-$1.80 billion. Adjusted EPS of $0.37 beat even the high end of that EPS range; $1.80 billion of sales was above some published estimates but essentially in line with the higher revenue view. That makes this a real, though not dramatic, earnings beat rather than merely a company-framed "strong" quarter. (Financial Highlights; Adjusted net income and EPS reconciliation)
| Metric | Q2 2026 | Q2 2025 | Versus expectation / prior period |
|---|---|---|---|
| Net sales | $1.796B | $1.730B | +3.8%; around published $1.77B-$1.80B estimates (Financial Highlights) |
| Adjusted diluted EPS | $0.37 | $0.36 | Above published ~$0.32-$0.35 consensus range (Adjusted net income and EPS reconciliation) |
| Adjusted EBITDA | $385.0M | $366.7M | +5.0%; margin up 20 bps to 21.4% (Adjusted EBITDA reconciliation) |
| Adjusted free cash flow | $200.1M | $169.7M | +17.9%, though it includes add-backs for integration and restructuring spending (Free cash flow reconciliation) |
| Full-year comparable sales growth outlook | 2%-4% | Prior: 1%-3% | Midpoint raised by 1 percentage point (2026 Outlook) |
| Full-year adjusted EBITDA outlook | $1.465B-$1.515B | Unchanged | No increase despite the higher sales outlook (2026 Outlook) |
The consequential change is the second sales-guide increase, not a higher profit target. Management lifted comparable sales growth to 2%-4% from 1%-3%, implying better demand than it had assumed. Regional spring-water sales rose 4.1% and premium-water sales jumped 30.5%, supporting that stronger top-line view. But adjusted EBITDA guidance remains $1.465-$1.515 billion, so the additional expected revenue is being offset by growth investment, costs, or both—not translating into a higher full-year earnings outlook. (Net Sales by Product Category; 2026 Outlook)
Underlying first-half profitability still trails last year, limiting the upside. First-half adjusted EBITDA fell to $691.0 million from $708.2 million and margin declined to 20.2% from 21.2%, even as second-quarter margin improved modestly. The Q2 recovery is encouraging, but the unchanged full-year EBITDA range says the filing does not yet establish a broad earnings acceleration. (Adjusted EBITDA reconciliation)
Cash generation improved, but leverage remains material. First-half operating cash flow increased to $331.7 million from $193.8 million, and adjusted free cash flow rose to $328.7 million from $224.4 million. Still, unadjusted free cash flow was only $109.0 million after $222.7 million of capital and intangible spending, while net debt stood at $4.88 billion and net leverage at 3.42x. The filing therefore improves the operating narrative without materially changing the balance-sheet constraint. (Cash Flow statement; Free cash flow reconciliation; Net leverage calculation)
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!